Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Shares Issued (2018 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Shares Issued for 8 consecutive years, with -$9.6 million as the latest value for Q4 2025.

  • Quarterly Shares Issued changed N/A to -$9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 24.72% year-over-year, with the annual reading at $1.6 million for FY2025, 24.72% up from the prior year.
  • Shares Issued for Q4 2025 was -$9.6 million at Rhythm Pharmaceuticals, up from -$22.9 million in the prior quarter.
  • The five-year high for Shares Issued was $161.7 million in Q1 2021, with the low at -$161.1 million in Q3 2021.
  • Average Shares Issued over 5 years is $3.5 million, with a median of $635000.0 recorded in 2024.
  • The sharpest move saw Shares Issued soared 49816.98% in 2021, then crashed 3932.33% in 2025.
  • Over 5 years, Shares Issued stood at $3.5 million in 2021, then crashed by 192.14% to -$3.2 million in 2022, then soared by 1533.55% to $46.4 million in 2023, then tumbled by 98.71% to $597000.0 in 2024, then tumbled by 1703.18% to -$9.6 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$9.6 million, -$22.9 million, and $31.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.